CK Life hits 17-month peak on patent application for cancer vaccines

CK Life Sciences Intl (Holdings)

11/04/2025 05:10

** CK Life Sciences 0775.HK soars as much as 41.7% to HK$0.68, highest since November 2023

** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse

** Healthcare and pharma products maker files Original Grant Patent application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines

** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co

** Stock up 17.1% YTD

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))